ZUERBLIS KENNETH J 4
4 · STEMLINE THERAPEUTICS INC · Filed Jun 28, 2019
Insider Transaction Report
Form 4
ZUERBLIS KENNETH J
Director
Transactions
- Award
Common Stock
2019-06-25+15,000→ 60,121 total
Footnotes (2)
- [F1]The restricted shares will vest according to the following schedule: 5,000 shares on 6/25/2020, 5,000 shares on 6/21/2021 and 5,000 shares on 6/25/2022.
- [F2]Of the 60,121 shares, 27,105 shares are restricted stock.